These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1110 related items for PubMed ID: 28803448

  • 1. Microvascular and lymphovascular tumour invasion are associated with poor prognosis and metastatic spread in renal cell carcinoma: a validation study in clinical practice.
    Bedke J, Heide J, Ribback S, Rausch S, de Martino M, Scharpf M, Haitel A, Zimmermann U, Pechoel M, Alkhayyat H, Shariat SF, Dombrowski F, Stenzl A, Burchardt M, Klatte T, Kroeger N.
    BJU Int; 2018 Jan; 121(1):84-92. PubMed ID: 28803448
    [Abstract] [Full Text] [Related]

  • 2. Lymphovascular invasion in clear cell renal cell carcinoma--association with disease-free and cancer-specific survival.
    Belsante M, Darwish O, Youssef R, Bagrodia A, Kapur P, Sagalowsky AI, Lotan Y, Margulis V.
    Urol Oncol; 2014 Jan; 32(1):30.e23-8. PubMed ID: 23428539
    [Abstract] [Full Text] [Related]

  • 3. Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma.
    Yildiz E, Ayan S, Goze F, Gokce G, Gultekin EY.
    BJU Int; 2008 Mar; 101(6):758-64. PubMed ID: 18070177
    [Abstract] [Full Text] [Related]

  • 4. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
    Brookman-May S, May M, Shariat SF, Xylinas E, Stief C, Zigeuner R, Chromecki T, Burger M, Wieland WF, Cindolo L, Schips L, De Cobelli O, Rocco B, De Nunzio C, Feciche B, Truss M, Gilfrich C, Pahernik S, Hohenfellner M, Zastrow S, Wirth MP, Novara G, Carini M, Minervini A, Simeone C, Antonelli A, Mirone V, Longo N, Simonato A, Carmignani G, Ficarra V, Members of the CORONA project and the SATURN project.
    Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
    [Abstract] [Full Text] [Related]

  • 5. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A, Novara G, Antonelli A, Bertini R, Billia M, Carmignani G, Cunico SC, Longo N, Martignoni G, Minervini A, Mirone V, Simonato A, Terrone C, Zattoni F, Ficarra V, Surveillance and Treatment Update on Renal Neoplasms (SATURN) Project, Leading Urological No-Profit Foundation for Advanced Research (LUNA) Foundation.
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [Abstract] [Full Text] [Related]

  • 6. Long-term outcome of small, organ-confined renal cell carcinoma (RCC) is not always favourable.
    Shindo T, Masumori N, Kobayashi K, Fukuta F, Hirobe M, Tonooka A, Hasegawa T, Kitamura H, Tsukamoto T.
    BJU Int; 2013 May; 111(6):941-5. PubMed ID: 23350965
    [Abstract] [Full Text] [Related]

  • 7. Microvascular tumour invasion in renal cell carcinoma: the most important prognostic factor.
    Dall'Oglio MF, Antunes AA, Sarkis AS, Crippa A, Leite KR, Lucon AM, Srougi M.
    BJU Int; 2007 Sep; 100(3):552-5. PubMed ID: 17555475
    [Abstract] [Full Text] [Related]

  • 8. Microscopic venous invasion is associated with disease free and cancer free survival in renal cell carcinoma.
    Sanli O, Zorba OU, Erdem S, Tezer M, Kilicar-Slan I, Esen T, Tunc M.
    Minerva Urol Nefrol; 2010 Dec; 62(4):347-53. PubMed ID: 20944535
    [Abstract] [Full Text] [Related]

  • 9. The role of lymphovascular space invasion in renal cell carcinoma as a prognostic marker of survival after curative resection.
    Katz MD, Serrano MF, Humphrey PA, Grubb RL, Skolarus TA, Gao F, Kibel AS.
    Urol Oncol; 2011 Dec; 29(6):738-44. PubMed ID: 19914106
    [Abstract] [Full Text] [Related]

  • 10. Predicting Oncologic Outcomes in Renal Cell Carcinoma After Surgery.
    Leibovich BC, Lohse CM, Cheville JC, Zaid HB, Boorjian SA, Frank I, Thompson RH, Parker WP.
    Eur Urol; 2018 May; 73(5):772-780. PubMed ID: 29398265
    [Abstract] [Full Text] [Related]

  • 11. Impact of Microscopic Wall Invasion of the Renal Vein or Inferior Vena Cava on Cancer-specific Survival in Patients with Renal Cell Carcinoma and Tumor Thrombus: A Multi-institutional Analysis from the International Renal Cell Carcinoma-Venous Thrombus Consortium.
    Rodriguez Faba O, Linares E, Tilki D, Capitanio U, Evans CP, Montorsi F, Martínez-Salamanca JI, Libertino J, Gontero P, Palou J.
    Eur Urol Focus; 2018 Apr; 4(3):435-441. PubMed ID: 28753848
    [Abstract] [Full Text] [Related]

  • 12. Prognostic significance of microvascular invasion in localized renal cell carcinoma.
    Sevinç M, Kirkali Z, Yörükoğlu K, Mungan U, Sade M.
    Eur Urol; 2000 Dec; 38(6):728-33. PubMed ID: 11111192
    [Abstract] [Full Text] [Related]

  • 13. Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC.
    Waldert M, Haitel A, Marberger M, Katzenbeisser D, Ozsoy M, Stadler E, Remzi M.
    BJU Int; 2008 Nov; 102(10):1381-4. PubMed ID: 18782311
    [Abstract] [Full Text] [Related]

  • 14. Microscopic venous invasion in renal cell carcinoma as a predictor of recurrence after radical surgery.
    Ishimura T, Sakai I, Hara I, Eto H, Miyake H.
    Int J Urol; 2004 May; 11(5):264-8. PubMed ID: 15147540
    [Abstract] [Full Text] [Related]

  • 15. Impact of several histopathological prognosticators and local tumour extension on oncological outcome in pT3b/c N0M0 renal cell carcinoma.
    Roos FC, Weirich J, Victor A, Elsässer A, Brenner W, Biesterfeld S, Hampel C, Thüroff JW.
    BJU Int; 2009 Aug; 104(4):461-9. PubMed ID: 19338563
    [Abstract] [Full Text] [Related]

  • 16. Perinephric and renal sinus fat infiltration in pT3a renal cell carcinoma: possible prognostic differences.
    Bedke J, Buse S, Pritsch M, Macher-Goeppinger S, Schirmacher P, Haferkamp A, Hohenfellner M.
    BJU Int; 2009 May; 103(10):1349-54. PubMed ID: 19076147
    [Abstract] [Full Text] [Related]

  • 17. Microscopic venous invasion: a prognostic factor in renal cell carcinoma.
    Lang H, Lindner V, Saussine C, Havel D, Faure F, Jacqmin D.
    Eur Urol; 2000 Nov; 38(5):600-5. PubMed ID: 11096243
    [Abstract] [Full Text] [Related]

  • 18. Prognostic implications of sarcomatoid and rhabdoid differentiation in patients with grade 4 renal cell carcinoma.
    Kara O, Maurice MJ, Zargar H, Malkoc E, Akca O, Andrade HS, Ramirez D, Caputo PA, Nelson RJ, Rini B, Kaouk JH.
    Int Urol Nephrol; 2016 Aug; 48(8):1253-1260. PubMed ID: 27215555
    [Abstract] [Full Text] [Related]

  • 19. Microvascular tumor invasion, tumor size and Fuhrman grade: a pathological triad for prognostic evaluation of renal cell carcinoma.
    Dall'Oglio MF, Ribeiro-Filho LA, Antunes AA, Crippa A, Nesrallah L, Gonçalves PD, Leite KR, Srougi M.
    J Urol; 2007 Aug; 178(2):425-8; discussion 428. PubMed ID: 17561167
    [Abstract] [Full Text] [Related]

  • 20. Nephron-sparing surgery for renal cell carcinoma: clinicopathologic features predictive of patient outcome.
    Krejci KG, Blute ML, Cheville JC, Sebo TJ, Lohse CM, Zincke H.
    Urology; 2003 Oct; 62(4):641-6. PubMed ID: 14550434
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.